The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells
(Q40617362)
scientific article published on November 1, 2003
scientific article published on November 1, 2003
Language:
Current Data About
The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells